An Assessment of the Safety and Pharmacokinetics of Ascending Doses of SANGUINATE™ in Healthy Volunteers.

NCT01847222 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to completion of competing study.

Conditions

Drug Safety

Interventions

BIOLOGICAL: SANGUINATE™
DRUG: Normal Saline Solution

Sponsor

Prolong Pharmaceuticals